Abstract. Little is known about the dynamics of pathology due to schistosomiasis following treatment. Public health authorities in endemic areas require such information to decide on the timing of treatment and re-treatment schedules. A study to assess the rate of clearance and reappearance of pathologic lesions due to Schistosoma haematobium using ultrasound has now been carried out in two schools in southeastern Tanzania, an area of moderateto-high transmission. Baseline data collection found urinary tract pathology in 67% of 533 children. Lesions of the bladder were significantly associated with egg positivity and microhematuria. The attributable fraction estimate of major bladder lesions due to S. haematobium was 75%. In a cohort study, 224 infected children were examined by ultrasound and then treated with a standard dose of 40 mg of praziquantel/kg of body weight. They were re-examined at two, four, six, 12, 18, and 24 months after treatment. Before treatment, 76% had pathologic lesions of the urinary tract. The proportion showing lesions decreased sharply during the first months after treatment to 11% at six months. At 24 months, lesions were detected in 57%, and 11% had developed new severe pathology. In 18 cases, pathology was present throughout, and 34 did not show any pathology throughout the study. This study provides the first detailed report on the evolution of urinary tract pathology due to S. haematobium infections at the community level. The results will help in making decisions on treatment and re-treatment schedules and more generally will provide a basis for designing control strategies in areas of moderate-to-high transmission.Various measures are used to assess infection and pathology due to Schistosoma haematobium.1 Egg counts are the standard indirect morbidity parameter measuring infection. Hematuria detected by reagent strips is another indirect measurement of urinary tract lesions in S. haematobium infections. Currently, schistosomiasis control programs in endemic areas aim at reducing morbidity in the population, 2 so it is important to document the prevalence of pathologic lesions before and after interventions. Ultrasound scanning of the urinary tract provides visible evidence of pathology. It is a safe tool that can be used in the field and is reliable, especially in detecting significant pathology. 3 The dynamics of clearance of pathologic lesions within six months after effective treatment with praziquantel in areas of mild-to-moderate transmission have been documented by Hatz and others using ultrasound. 4 Little is known about the dynamics of pathology after clearance in areas with continuous re-exposure. Such information is clearly required to reach informed decisions on treatment and re-treatment schedules. Based on previous experience in the same area, 4 the present study was designed to assess the evolution of pathology after treatment, and the severity and the incidence of reappearance of lesions due to S. haematobium in an area of moderate-to-high transmission over a peri...